SCM
AGN

Steadfast Capital Management’s Allergan plc AGN Stock Holding History

Steadfast Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-143,500
Closed -$36.9M – 71
2014
Q4 		$36.9M Hold
143,500
– – 0.58% 40
2014
Q3 		$34.6M Buy
+143,500
New +$32.1M 0.59% 46

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Steadfast Capital Management's AGN Position: Q2 2017 in Review

Steadfast Capital Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 122,683 shares — an estimated $29.3M sold.

Steadfast Capital Management first reported a position in AGN in Q4 2013 and held it in 13 quarters. The position peaked at $706M in Q1 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Steadfast Capital Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Steadfast Capital Management sold 122,683 Allergan plc shares in Q2 2017, an estimated $29.3M.
  • Steadfast Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 13 quarters.
  • Steadfast Capital Management's Allergan plc position peaked at $706M in Q1 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Steadfast Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.